HDMTX-based induction therapy followed by consolidation with conventional systemic chemotherapy and intraventricular therapy (modified Bonn protocol) in primary CNS lymphoma: a monocentric retrospective analysis-Reference-Cited by-同舟云学术

HDMTX-based induction therapy followed by consolidation with conventional systemic chemotherapy and intraventricular therapy (modified Bonn protocol) in primary CNS lymphoma: a monocentric retrospective analysis

Published:2019-06-20 Issue:1 Volume:1 Page:
ISSN:2524-3489
Container-title:Neurological Research and Practice
language:en
Short-container-title:Neurol. Res. Pract.

Author:

Seidel Sabine^ORCID,Korfel Agnieszka,Kowalski Thomas,Margold Michelle,Ismail Fatme,Schroers Roland,Baraniskin Alexander,Pels Hendrik,Martus Peter,Schlegel Uwe

Publisher

Springer Science and Business Media LLC

Subject

Automotive Engineering

Link

http://link.springer.com/content/pdf/10.1186/s42466-019-0024-2.pdf

Reference33 articles.

1. Ostrom, Q. T., Gittleman, H., Liao, P., Rouse, C., Chen, Y., Dowling, J., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. (2014). CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro-Oncology, 16(Suppl 4), iv1–i63. https://doi.org/10.1093/neuonc/nou223 .

2. Korfel, A., & Schlegel, U. (2013). Diagnosis and treatment of primary CNS lymphoma. Nature Reviews Neurology, 9(6), 317–327. https://doi.org/10.1038/nrneurol.2013.83 .

3. Nelson, D. F. (1999). Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL). Journal of Neuro-Oncology, 43, 241–247.

4. Abrey, L. E., Yahalom, J., & DeAngelis, L. M. (2000). Treatment for primary CNS lymphoma: The next step. Journal of Clinical Oncology, 18, 519–526.

5. Thiel, E., Korfel, A., Martus, P., Kanz, L., Griesinger, F., Rauch, M., Röth, A., Hertenstein, B., von Toll, T., Hundsberger, T., Mergenthaler, H. G., Leithäuser, M., Birnbaum, T., Fischer, L., Jahnke, K., Herrlinger, U., Plasswilm, L., Nägele, T., Pietsch, T., Bamberg, M., & Weller, M. (2010). High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncology, 11(11), 1036–1047. https://doi.org/10.1016/S1470-2045(10)70229-1 .

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary central nervous system lymphoma (PCNSL) in older patients;Current Opinion in Oncology;2023-07-17

2. Outcome and prognostic factors of very old patients with primary CNS lymphoma: a retrospective analysis of patients ≥80 years treated with high-dose methotrexate-based chemotherapy;Leukemia & Lymphoma;2022-07-20

3. High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity;Cancers;2022-04-23

4. Patients with Primary Central Nervous System Lymphoma Not Eligible for Clinical Trials: Prognostic Factors, Treatment and Outcome;Cancers;2021-06-11

5. Mental time travel in patients “cured” from primary central nervous system lymphoma;Journal of Clinical and Experimental Neuropsychology;2021-03-16